Page 9 - Kristen Zannella News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kristen zannella. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kristen Zannella Today - Breaking & Trending Today

Applied BioMath, LLC to Present at PEGS Summit


Applied BioMath, LLC to Present at PEGS Summit
News provided by
Share this article
CONCORD, Mass., May 4, 2021 /PRNewswire/ Applied BioMath (
www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development today announced their participation at the PEGS Summit occurring virtually May 11-13, 2021.
John Burke, PhD, Co-founder, President and CEO of Applied BioMath will present Applied BioMath Assess™ - An Early Feasibility Assessment Tool for Biotherapeutics within the conference program, Advancing Bispecific Antibodies and Combination Therapy to the Clinic on Tuesday, May 11th at 10:40 a.m. ET. In this presentation, Dr. Burke will demonstrate how Applied BioMath s new and interactive software tool systematically investigates the therapeutic characteristics (e.g., format, half-life, affinity, mechanism of action) given target characteristics (e.g., targ ....

Lucia Wille , John Burke , Kristen Zannella , Applied Biomath , Biomath Assess , Early Feasibility Assessment Tool , Advancing Bispecific Antibodies , Combination Therapy , Multi Specific Antibody Design , Mechanistic Avidity , Engineering Bispecific Antibodies , லூசியா வில்லே , ஜான் பர்க் , சேர்க்கை சிகிச்சை ,

Applied BioMath, LLC to Hold Virtual Quantitative Systems Pharmacology Summit April 6th-8th


Share this article
Share this article
CONCORD, Mass., March 9, 2021 /PRNewswire/ Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk therapy research and development, today announced they will host a virtual Quantitative Systems Pharmacology (QSP) Summit Tuesday, April 6th - Thursday, April 8th occurring 11 a.m. - 1 p.m. ET each day.
The QSP Summit is an annual meeting dedicated to fostering an active community of industry and academic participants interested in utilizing computational biology approaches including QSP modeling. Registrants are encouraged to submit a poster abstract for the virtual poster session. Undergraduate and graduate students as well as postdocs are eligible to receive poster prizes with first place receiving $150, second place receiving $100, and third place receiving $50. Six poster abstracts will be selected for lightning presentations d ....

Samuel Isaacson , Mike Rosenblatt , Raman Singh , Sergio Iadevaia , John Burke , Kristen Zannella , Student At University Buffalo , Professor At Boston University , Quantitative Systems Pharmacology , Summit Tuesday , Yuan Chang , Graduate Student , Scientific Director , Data Analysis , Associate Professor , Senior Clinical Pharmacokineticist , Chief Medical Officer , Flagship Pioneering , Associate Director , Cell Therapies , Applied Biomath , சாமுவேல் ஐஸக்‌ஸந் , மைக் ரோசன்ப்ளாட் , ஒரு மனிதன் சிங் , ஜான் பர்க் , மாணவர் இல் பல்கலைக்கழகம் எருமை ,

Applied BioMath, LLC Announces Collaboration with Immunitas Therapeutics


Applied BioMath, LLC Announces Collaboration with Immunitas Therapeutics
News provided by
Share this article
Share this article
CONCORD, Mass., March 2, 2021 /PRNewswire/ Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced their collaboration with Immunitas Therapeutics, Inc. (www.immunitastx.com) for the development of a systems pharmacology model for an oncology pathway with complex receptor-ligand dynamics. The model will be used to understand the importance of targeting multiple receptors simultaneously and will inform the optimal therapeutic modality. Efficiently translating early research into a clinical candidate is a top priority at Immunitas, said Tarek Samad, CSO of Immunitas. We look forward to leveraging Applied BioMath s mathematical models to better understand the best path forward for this therap ....

John Burke , Kristen Zannella , Tarek Samad , Immunitas Therapeutics Inc , Immunitas Therapeutics , Applied Biomath , ஜான் பர்க் , தரெக் சமத் ,

Applied BioMath, LLC Announces Collaboration with Immunitas Therapeutics

Applied BioMath, LLC Announces Collaboration with Immunitas Therapeutics
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

John Burke , Kristen Zannella , Tarek Samad , Immunitas Therapeutics Inc , Immunitas Therapeutics , Applied Biomath , ஜான் பர்க் , தரெக் சமத் ,

Applied BioMath, LLC Announces that Revitope Oncology is extending its Collaboration on Systems Pharmacology Modeling in Solid Tumors


Applied BioMath, LLC Announces that Revitope Oncology is extending its Collaboration on Systems Pharmacology Modeling in Solid Tumors
News provided by
Share this article
Share this article
CONCORD, Mass., Feb. 9, 2021 /PRNewswire/ Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced that Revitope Oncology is extending its collaboration to develop a systems pharmacology model for Revitope s dual antigen targeting
TwoGATE™ platform for solid tumor indications. Our previous collaborations with Applied BioMath proved extremely valuable as we leveraged their models to identify optimal therapeutic parameters in our development process, said Werner Meier, CSO of Revitope Oncology. We look forward to extending our prior collaboration with this project to help accelerate our lead pipeline candidate towards the cli ....

United Kingdom , Werner Meier , John Burke , Kristen Zannella , Revitope Oncology Inc , Revitope Oncology , Applied Biomath , ஒன்றுபட்டது கிஂக்டம் , வெர்னர் மையர் , ஜான் பர்க் ,